Back
Peter Marks

Peter Marks

Non-Executive Director and Deputy Chairman

B.Econ; LL.B; Grad Dip. Comm.Law;  (all Monash Univ.) MBA (Scottish Business School, Edinburgh)

Mr Peter Marks has over 35 years’ experience in corporate advisory and investment banking. Over the course of his career, he has specialised in capital raising IPO's, cross border capital raisings, M&A transactions, corporate underwriting and venture capital transactions for companies based in Australia, the US and Israel. He has been involved in a broad range of transactions with a special focus in the life-sciences, biotechnology, medical technology and high tech as well as the mining sector. Peter has served as both an Executive and Non-Executive Director of a number of different entities, many of which have been listed on the ASX, Nasdaq and AIM markets.


Peter currently holds Board positions with the following listed entities -Alterity Therapeutics Limited (ASX: ATH), Iris Metals Ltd (ASX:IR1) and Evergreen Lithium Ltd (EG1), and is a former Board member of Fluence Corporation Limited (ASX: FLC), Elsight Limited (ASX: ELS) and Nyrada Inc. (ASX:NYR). He is also a Board member of unlisted hydrogen company, Electriq Global Ltd. He also sits and has sat on the Audit and Remuneration Committees for several of the abovementioned companies.


Peter holds a Bachelor of Economics, a Bachelor of Law and a Graduate Diploma in Commercial Law from Monash University, Australia. He also holds an MBA from the University of Edinburgh, Scotland.